These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 12458679

  • 1. Albugranin, a recombinant human granulocyte colony stimulating factor (G-CSF) genetically fused to recombinant human albumin induces prolonged myelopoietic effects in mice and monkeys.
    Halpern W, Riccobene TA, Agostini H, Baker K, Stolow D, Gu ML, Hirsch J, Mahoney A, Carrell J, Boyd E, Grzegorzewski KJ.
    Pharm Res; 2002 Nov; 19(11):1720-9. PubMed ID: 12458679
    [Abstract] [Full Text] [Related]

  • 2. The induction of prolonged myelopoietic effects in monkeys by GW003, a recombinant human granulocyte colony-stimulating factor genetically fused to recombinant human albumin.
    Xu X, Yang J, Liu Y, Shan C, Wang Q, Chen Z, Cheng Y.
    J Pharm Sci; 2015 Feb; 104(2):760-7. PubMed ID: 25174614
    [Abstract] [Full Text] [Related]

  • 3. The transepithelial transport of a G-CSF-transferrin conjugate in Caco-2 cells and its myelopoietic effect in BDF1 mice.
    Widera A, Bai Y, Shen WC.
    Pharm Res; 2004 Feb; 21(2):278-84. PubMed ID: 15032309
    [Abstract] [Full Text] [Related]

  • 4. Evidence that the granulocyte colony-stimulating factor (G-CSF) receptor plays a role in the pharmacokinetics of G-CSF and PegG-CSF using a G-CSF-R KO model.
    Kotto-Kome AC, Fox SE, Lu W, Yang BB, Christensen RD, Calhoun DA.
    Pharmacol Res; 2004 Jul; 50(1):55-8. PubMed ID: 15082029
    [Abstract] [Full Text] [Related]

  • 5. Extended activity in cynomolgus monkeys of a granulocyte colony-stimulating factor mutein conjugated with high molecular weight polyethylene glycol.
    Eliason JF, Greway A, Tare N, Inoue T, Bowen S, Dar M, Yamasaki M, Okabe M, Horii I.
    Stem Cells; 2000 Jul; 18(1):40-5. PubMed ID: 10661570
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and Pharmacodynamics of Two Formulations of Pegylated Recombinant Human Granulocyte Colony-Stimulating Factor in Healthy Chinese Subjects: An Open-Label, Randomized, Parallel-Design Bioavailability Study.
    Hu C, Ji B, Hu X, Yang C, Sun W, Zhao X, Li L, Li X, Zhang L.
    Clin Pharmacol Drug Dev; 2021 Mar; 10(3):291-298. PubMed ID: 32567217
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic and pharmacodynamic profile of new biosimilar filgrastim XM02 equivalent to marketed filgrastim Neupogen: single-blind, randomized, crossover trial.
    Lubenau H, Bias P, Maly AK, Siegler KE, Mehltretter K.
    BioDrugs; 2009 Mar; 23(1):43-51. PubMed ID: 19344191
    [Abstract] [Full Text] [Related]

  • 9. Relationship between absolute neutrophil count profiles and pharmacokinetics of DA-3031, a pegylated granulocyte colony-stimulating factor (pegylated-G-CSF): a dose block-randomized, double-blind, dose-escalation study in healthy subjects.
    Ahn LY, Shin KH, Lim KS, Kim TE, Jeon H, Yoon SH, Cho JY, Shin SG, Jang IJ, Yu KS.
    Clin Drug Investig; 2013 Nov; 33(11):817-24. PubMed ID: 24078278
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects.
    Akizuki S, Mizorogi F, Inoue T, Sudo K, Ohnishi A.
    Bone Marrow Transplant; 2000 Nov; 26(9):939-46. PubMed ID: 11100272
    [Abstract] [Full Text] [Related]

  • 12. Effect of escalating doses of recombinant human granulocyte colony-stimulating factor (filgrastim) on circulating neutrophils in healthy subjects.
    Borleffs JC, Bosschaert M, Vrehen HM, Schneider MM, van Strijp J, Small MK, Borkett KM.
    Clin Ther; 1998 Nov; 20(4):722-36. PubMed ID: 9737832
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An increase in peripheral blood progenitor cells in primates by coadministration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
    Suzuki H, Ikebuchi K, Wada Y, Okano A, Nakamiya T, Akiyama Y, Sawada T, Asano S, Nakahata T.
    Transplantation; 1997 Nov 27; 64(10):1468-73. PubMed ID: 9392313
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.